The postoperative pain management market is witnessing steady growth, driven by the rising number of surgical procedures globally and increasing awareness of effective pain control. Advancements in ...

Percheron Therapeutics Ltd earlier this week reported new preclinical data showing that its investigational cancer drug HMBD-002 substantially ...

Frazier Life Sciences (FLS), a US investment firm focused on innovative therapeutics, has announced the closing of its ...

Percheron Therapeutics Ltd CEO Dr James Garner talked with Proactive about promising new preclinical data for the company’s investigational cancer ...

The Palo Alto-based venture firm Frazier Life Sciences has closed a new venture capital fund for startup creation and investing in early-stage biotechnology companies, raising $1.3 billion.